Reperfusion injury (RI), a potential life-threatening disorder, represents an acute infl ammatory response after periods of ischemia resulting from myocardial infarction, stroke, surgery, or trauma. The recent identifi cation of a monoclonal natural IgM that initiates RI led to the identifi cation of nonmuscle myosin heavy chain type II A and C as the self-targets in two different tissues. These results identify a novel pathway in which the innate response to a highly conserved self-antigen expressed as a result of hypoxic stress results in tissue destruction.
Nucleated cells are highly sensitive to hypoxia, and even short periods of ischemia in multicellular organisms can have dramatic eff ects on cellular morphology, gene transcription, and enzymatic processes. Mitochondria, as the major site of oxygen metabolism, are particularly sensitive to changes in oxygen tension and during hypoxia release reactive oxygen species (ROS), which chemically modify intracellular constituents such as lipids and induce damage to DNA leading to cell injury and death (1, (2) (3) (4) (5) . In addition to endogenous intracellular events, ischemic tissue triggers an acute infl ammatory response that enhances cell injury, resulting in necrosis. One current view is that ROS-modifi ed structures formed during ischemia stimulate infi ltration of infl ammatory cells that mediate an acute infl ammatory response leading to additional cell injury and death (6) . However, this mechanism alone does not completely explain the acute nature of reperfusion injury (RI), because injury occurs even when infl ammatory cells are limited (7, 8) . Accumulating evidence supports a major role for the serum innate response, namely natural IgM and the complement system. Early observations that transient depletion of complement C3 reduced infl ammation in a rat model of myocardial infarction suggested a role for innate immunity in RI (9) . Subsequently, Weisman et al. demonstrated that pretreatment of rats with a specifi c soluble inhibitor of complement C3 (sCR1) dramatically reduced injury in a similar model of myocardial infarction and further established the importance of complement as a mediator of injury (10) . Subsequent studies using the sCR1 inhibitor in various animal models, including porcine (11, 12) and mouse (13) , and in various tissues as diverse as the central nervous system, intestine, or skeletal muscle confi rmed and generalized the concept that the complement system was an important mediator of RI. Although the complete mechanism of injury is not clear, a role for the complement membrane attack complex (C5-C9) is supported by observations of deposition of complement C9 within reperfused heart tissues (14, 15) , reduction in injury in mice defi cient in C5 or treated with C5-specifi c antibody (16) (17) (18) (19) , and C6-defi cient rabbits (20, 21) . Importantly, RI injury in the skeletal muscle model is not only complement dependent but requires intact mast cells, as mice defi cient in mast cell protease 5, one of the chymotryptic proteases found in granules, are protected from full injury (22) .
The fi rst indication that natural antibody was involved in initiation of RI derived from studies in mouse models bearing complete defi ciencies in innate immune proteins such as complement components C3 and C4 and natural IgM. Results from these studies suggested that brief periods of ischemia led to an alteration in surface epitopes, and this change resulted in binding by natural IgM and activation of the complement system (23, 24) . Further support that specifi c natural IgM was involved followed from two separate reports that mice defi cient in complement receptors CD21 and CD35 were protected in an intestinal model of RI despite a normal level of circulating IgM (25, 26) . Reconstitution of the animals with pooled IgM (isolated from WT mice) or engraftment with WT peritoneal B-1 cells restored pathogenic IgM and RI. Notably, reconstitution of Cr2 −/− mice with pooled murine IgG alone did not restore histological injury but enhanced neutrophil infi ltration when combined with IgM (25) . Most recently, identifi cation of a single monoclonal IgM from a panel of B-1 cell hybridomas, which alone could restore injury in both intestine and hindlimb models of RI in antibody-defi cient (RAG-1 −/− ) mice, provided further support for the hypothesis that innate recognition of stress-induced self-antigens was involved in initiation of RI (27, 28) .
In this paper, we identifi ed a highly conserved region within nonmuscle myosin heavy chain (Hc) type II (NMHC-II) A and C as the target for natural IgM and initiation of injury in murine models of skeletal and intestinal RI. Five lines of evidence are provided that support a role for NMHC-II as the critical self-ligand in RI: (a) protein sequence analysis of natural IgM-bound NMHC-II isolated from lysates of RI tissue; (b) binding of NMHC-II by pathogenic IgM (IgM ) in an ELISA assay; (c) initiation of intestinal RI in RAG-1 −/− mice with an anti-pan-myosin antibody; (d) sequence homology with a synthetic peptide isolated from phage display library that binds pathogenic IgM CM-22 and blocks intestinal RI in WT mice; and (e) a synthetic peptide representing a conserved region of NMHC-II binds IgM CM-22 in vitro and blocks RI in WT mice in two distinct tissues. Collectively, these results support the model that natural IgM recognition of NMHC-II expressed on the surface of ischemic tissue results in activation of the complement system and acute infl ammation. These fi ndings suggest a general mechanism by which stress, such as hypoxia, leads to expression of a highly conserved self-antigen on the cell surface and recognition by the innate immune system resulting in acute infl ammation. These observations represent a clear example of the novel concept "innate autoimmunity" (29, 30) .
RESULTS

Immune precipitation of self-antigens with natural IgM
The identifi cation of a B-1 cell hybridoma clone (IgM ) that binds ischemic tissue in the murine intestinal and skeletal muscle models of RI provided support for the hypothesis that 
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ischemic tissue was altered relative to normal tissue and that neoepitopes expressed or exposed during ischemia were targets for an innate response to self (27, 28) . Moreover, the availability of a specifi c IgM provided a means to identify the neoepitope. The rationale was that circulating IgM would bind self-antigens exposed during ischemia and that these complexes could be isolated and the antigens identifi ed by proteomic techniques. RAG-1 −/− mice were reconstituted with an optimal amount of IgM , treated for intestinal ischemia, and reperfused for 0 or 15 min before harvesting of tissues. Immune complexes of IgM antigen were isolated from lysates of jejuneum at the two time points and fractionated by SDS-PAGE under reducing conditions. Analysis of the stained gels indicated common bands at varying molecular masses for all time points, including the sham control (Fig.  1 A) . However, at 15 min an apparent unique band at high molecular mass ‫052ف(‬ kD) was identifi ed (Fig. 1 A) . Protein bands were excised from stained gels and enzymatically digested, and peptides were analyzed by tandem mass spectrometry as described previously (31) . Analysis of eluted peptides indicated that the common bands at ‫,52ف‬ 50, and 75 kD represented immunoglobulin light chain and IgG and IgM Hc, respectively. The IgG Hc band at 50 kD was identifi ed as goat and most likely represents Ig eluting from the beads, whereas the 75-kD band represents murine IgM Hc. Analysis of the high molecular mass band yielded peptide sequences homologous to NMHC-II isoforms A and C (Table I ). In similar experiments using lysates prepared from WT mice treated for 3 h in intestinal RI, a similar size band at 250 kD was also observed and sequence analysis identifi ed NMHC-II A and C peptides (unpublished data).
Three forms (A, B, and C) of NMHC-II have been identifi ed in the mouse and human genomes (32, 33) . All eukaryotic cells express NMHC-II, but the distribution of the three isoforms varies. NMHC-II A and B are ‫%58ف‬ homologous, whereas NMHC-II C is ‫%56ف‬ similar to A and B (32) . The three isotypes are highly conserved among mice and humans. As a further test for binding of IgM to NMHC-II, an ELISA approach was followed. Plates were coated with antibody specifi c for each of the three forms of NMHC-II or with a pan-myosin antibody to capture the relevant antigen from lysates prepared from jejuneum of RAG-1 −/− mice. Subsequently, IgM CM-22 (or IgM CM-31 ) was added and developed with a labeled anti-mouse IgM antibody. Above background binding of IgM but not IgM CM-31 to all three of the isoforms of NMHC-II was observed (Fig. 1 B) . The combined sequence analysis and ELISA results suggest that IgM CM-22 recognizes a conserved region of the type II NMHC. As a further test of whether myosin is exposed to circulating antibody after ischemia, RAG-1 −/− mice were reconstituted with a purifi ed IgG fraction of rabbit anti-panmyosin Hc. No evidence of rabbit IgG deposition was observed in tissues of reconstituted but sham-treated mice (unpublished data). In contrast, ischemic RAG-1 −/− mice reconstituted with the myosin-specifi c IgG before reperfusion developed signifi cant RI compared with saline controls (33 ± 11 vs. 11 ± 8; P < 0.05; Fig. 1 C) . These results provide further support that myosin is exposed to antibody in circulation after ischemia. However, they did not identify the epitope within NMHC-II.
Identifi cation of an IgM CM-22 ligand by phage display As an alternative approach to identify the IgM CM-22 target self-antigen, an M13 phage display library of random 12-mer amino acid sequences was screened with the specifi c IgM. After four rounds of positive selection with IgM CM-22 and two rounds with negative selection with a control IgM (clone CM-75), 10 phage clones were isolated and the nucleotide sequence of the relevant M13 gene was analyzed. Notably, all 10 clones bore a codon sequence rich in asparagine. Four best binders to IgM CM-22 were selected and one of these clones, P8 (which bound with the highest effi ciency), was further characterized (Table II and Fig. 2 A) . A 12-amino acid peptide (P8) was synthesized based on the phage sequence and assayed for inhibition of phage P8 binding to IgM (Fig. 2 B) . Titration of increasing amounts of P8 peptide yielded 50% inhibition at an estimated concentration of 10-100 µM. This assay indicates a reasonable overall avidity of binding based on multiple binding sites expressed on the phage surface. This result also suggests that IgM binding to phage P8 is specifi c for the peptide region and that the synthetic peptide could be used as a mimetope for the actual antigen. To further characterize binding of P8 peptide to IgM , ELISA plates were coated with the peptide and tested with varying concentrations of IgM CM-22 or control IgM CM-75 for binding (Fig. 2 C) . At the lower concentration of 1 µg/ml, neither IgM bound above background. However, at 10 µg/ml signifi cantly more IgM CM-22 bound than IgM CM-75 (P < 0.05). 
Immunoprecipitations were performed as described in Materials and methods. Bands obtained from SDS-PAGE were digested and extracted for protein identifi cation by tandem mass spectrometry. Peptides identifi ed from the RI-specifi c 250-kD band were matched to isoforms A and C from NMHC-II. The Mascot score is defi ned as −10 × Log(P), where P is the probability that the observed match is a random event. Individual ion scores >53 indicate identity or extensive homology (P < 0.05).
To test whether synthetic peptide P8 blocked IgM CM-22 in vivo, antibody-defi cient (RAG-1 −/− ) mice were reconstituted with pathogenic IgM with or without the peptide. Previous studies had demonstrated that intestinal RI in RAG-1 −/− mice was IgM-dependent and that IgM CM-22 alone was sufficient to restore injury (24, 27) . As expected, reconstitution of RAG-1 −/− mice with IgM CM-22 but not saline before reperfusion resulted in RI ( (27) . Thus, peptide P8 appears to block binding of IgM and induction of injury in vivo.
To test whether peptide P8 represented a mimetope for a major self-antigen, WT mice were pretreated with peptide P8 (serum concentration of ‫01ف‬ µM) 5 min before reperfusion in the intestinal model. Analysis of jejuneum tissues of mice treated with a similar concentration of control peptide or saline before reperfusion identifi ed signifi cant injury to the microvilli, as expected (P < 0.05; Fig. 3 A, iii). In contrast, pretreatment of WT mice with peptide P8 5 min before reperfusion blocked apparent injury relative to saline or control peptide (mean pathology score = 5 ± 3 vs. 24 ± 16 and 23 ± 19, respectively; P < 0.005 and P < 0.027, respectively; Fig. 3 , A [iv] and B). As expected, IgM, C4, and C3 colocalized within microvilli of RI-treated WT mice but not in mice administered P8 peptide (unpublished data). These results suggest that the number of key epitopes required to initiate RI is limited as a single peptide blocks injury and deposition of IgM and complement. 
Peptides identifi ed by screening phage display library with IgM CM-22 . Sequence of peptide region of phage clone P8 and consensus sequence based on 10 phage clones isolated from an IgM CM-22 -selected pool of M13 phage display library. Alignment of conserved regions of three isoforms of mouse and human NMHC-II is also provided. The corresponding amino acid positions in each isoform are listed in the parentheses. N2 peptide corresponds to the mouse and human NMHC-II C sequence.
Identifi cation of self-peptide that binds IgM CM-22
Comparison of the sequences of the three NMHC-II isoforms with the P8 peptide sequence identifi ed one region of apparent homology (Table II) . All three isoforms include a motif of NxxxxNxNx that suggested similarity with the P8 sequence. A 12-amino acid synthetic peptide (referred to as N2) sequence (represents the NMHC-II C isoform) was prepared for further study. To test whether this region bound to IgM CM-22 , surface plasmon resonance (SPR) analysis was used (Fig. 4) . N2 peptide was injected over a surface coupled with IgM CM-22 (Fig. 4 A) and generated a robust response, which corresponded to a KD of 123 ± 61 μM (mean ± SD; n = 2) as calculated from the steady-state response levels (Fig.  4 C) . In contrast, no binding was observed when a control peptide was injected over the specifi c IgM-coupled surface (Fig. 4 B) or when the N2 peptide was injected over a surface coupled with the IgM CM-31 control IgM (Fig. 4 D) .
Self-peptide blocks intestinal RI injury
To test whether NMHC N2 peptide represents the major self-epitope in intestinal RI, WT mice were treated with saline or increasing concentrations of the synthetic peptide (fi nal serum concentrations = 8, 16, 32, or 40 µM, respectively) 5 min before reperfusion in the intestinal model. Histological analysis of tissue sections of saline-treated WT mice identifi ed injury that correlated with deposition of IgM and complement as expected ( To further evaluate the protection by N2 peptide, mice were characterized for intestinal permeability. In this assay mice are administered horseradish peroxidase (HRP) enterally 10 min before ischemia, and uptake into circulation is [n = 10 and 8, respectively]; P < 0.05; Fig. 5 C) . Thus, pretreatment of mice with N2 peptide protects from both histological injury and intestinal permeability.
Protection from injury correlated with a reduction in deposition of IgM and complement in mice treated with 40 µM N2 peptide (Fig. 5 D, v-viii) . Notably, among the control mice not all animals developed full injury even though treatment with N2 (or P8) peptide gave substantial protection. We speculate that the range in injury observed among WT 
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mice is caused by a variation in serum levels of specifi c natural IgM because this pattern is not observed in RAG-1 −/− mice treated with IgM (Fig. 3) . Moreover, IgM and complement deposition correlate with the level of injury; i.e., WT mice with a low injury score have low level of IgM (unpublished data).
Previous reports identifi ed vascular permeability of labeled albumin as a measure of severity of intestinal RI (23, 26, 27) . To evaluate further the eff ects of treatment with N2 peptide in the intestinal RI model, we used an intravital approach combined with a novel miniaturized laser scanning confocal microscope to image leakage of microvessels within the villi of the jejunum. In this approach anesthetized mice are administered a fl uorescent-labeled vascular probe (AngioSense 680) that circulates within normal blood vessels for up to 2 h. Besides its stability in circulation, an advantage of this novel probe is that it emits in the near infrared and, thus, imaging is in the low energy range. To image circulation within the microvilli, a scanning confocal stick lens (approximately the diameter of a biopsy needle) is inserted within a small incision in the wall of the jejuneum and placed in direct contact with the mucosal surface. Contrast is provided by pretreatment of mice i.v. with Rhodamine 6G, which is taken up by cells, especially the enterocytes lining the microvilli. Mice are injected with the vascular probe 5 min before reperfusion, and imaging is initiated 15 min after reperfusion. For example, among the sham controls, the blood vessels within the lamina propria of microvilli are identifi ed by the circulating vascular probe (red), which is contrasted by the green stain of the enterocytes (Rhodamine 6G; Fig. 6 A, i) . In experimental mice, signifi cant leakage of the vascular probe is observed as early as 20 min after reperfusion, as indicated by the presence of red dye within the lamina propria and surrounding target tissues. The mean ratio of vessel (V) to background (B) is 149 ± 14 versus 16 ± 4 in arbitrary units for sham controls and saline-treated mice, respectively (P < 0.001; Fig. 6, A [ii] and B). In contrast, limited leakage of the vascular probe was observed in experimental mice pretreated with N2 peptide (153 ± 4 vs. 149 ± 14 units for N2-and saline-treated mice, respectively; P < 0.001; Fig. 6, A [iii] and B). Thus, administration of an optimal amount of N2 peptide 5 min before reperfusion eff ectively limited leakage of the vascular probe.
Self-peptide blocks RI injury in skeletal muscle
The identifi cation of a single self-peptide that blocks intestinal RI in WT mice led to the general question of whether the N2 region of NMHC-II was also the target for pathogenic IgM among other ischemic tissues. It might be predicted that the number of antibodies specifi c for ischemic tissue is limited based on the current understanding that the repertoire of natural IgM is relatively small (35-37) and putatively selected through evolution (38, 39) . Moreover, ligands of natural IgM are considered highly conserved structures and are probably limited in number.
To test whether NMHC-II represents the self-ligand target in the murine hindlimb model, mice were treated for 2 h of ischemia followed by 3 h of reperfusion as described previously (28) . As expected, WT mice administered saline or 40-μM control peptide (Table II) developed considerable injury. In contrast, injury was signifi cantly reduced in mice administered 40 μM (fi nal serum concentration) of N2 peptide before reperfusion (mean number of injured muscle fi bers per 50 counted = 25 ± 4 and 22 ± 3 for saline and control peptide, respectively, vs. 12 ± 1 for N2 treated; P < 0.01 and P < 0.05, as determined by Student's t test between saline and control peptide and N2 and control peptide, respectively; P < 0.05 for all groups, as determined by analysis of variance [ANOVA]) (Fig. 7, A and B) . Thus, these results suggest that, as in the intestinal model, NMHC-II is the major self-ligand in ischemic skeletal muscle. 
DISCUSSION
The recent identifi cation of a natural antibody (IgM ) that initiates intestinal and skeletal muscle RI in antibodydefi cient mice has provided an important reagent to isolate and characterize the self-antigen involved in initiation of acute infl ammation (27, 28) . In this paper, we provide fi ve lines of evidence that support the identifi cation of the selfantigen as a highly conserved region (represented by N2 peptide) within NMHC-II. Notably, pretreatment of WT mice with N2 peptide (or the mimetope P8) after ischemia but before reperfusion dramatically reduced RI within both intestinal and skeletal muscle models.
15 types of myosin Hc have been identifi ed to date. Like other myosins, the NMHC-II form hexamers of two Hc ‫052ف(‬ kD each) and two pair of regulatory light chains (20 and 17 kD each). Functionally, they all bear ATPase activity, form molecular motors within the cell, and are thought to be important in regulating cytokinesis, cell motility, and cell polarity (40) . Of the three isoforms, little is known of the functional importance of the recently identifi ed NMHC-II C.
Studies in cell culture and in isolated hearts made ischemic and reperfused in the absence of blood cells or sera reveal evidence of cell injury to cardiomyocytes, suggesting that factors independent of infl ammation can lead to cell injury (2, 41) . One well-characterized pathway is poly(ADP ribose) synthetase (PARS), which is a nuclear enzyme involved in DNA strand break repair (3). Damage to chromatin by free radicals resulting from ROS, which form during hypoxia, leads to activation of PARS that has multiple eff ects, including depletion of mitochondrial ATP and eventual cell injury. Although the eff ects of hypoxia on NMHC-II have not been reported, one possible link with generation of ROS and activation of the PARS pathway is that nonmuscle myosins, which are involved in maintaining cell morphology, migrate to the outer membrane after cell injury (42) . Thus, a general explanation for the combined pathways is that NMHC-II is mobilized to the cell surface by hypoxia-related events resulting in transient exposure of the N2 region on the outer cell surface of endothelium and muscle cells. This exposure would provide a target for circulating pathogenic IgM resulting in enhancement of cell injury beyond that caused by endogenous intracellular pathways such as PARS. We propose that the NMHC-II epitope is exposed on hypoxic cells and not released as a result of cell death. If the latter were the case, multiple other self-antigens would be released and also serve as targets for circulating natural IgM, which binds many intracellular antigens. Based on the direct visualization of vascular leakage, it seems most probable that injury is initiated at the endothelium surface.
Expression of novel cell surface molecules in response to stress is not unprecedented, although examples are generally based on in vitro study. For example, a recent report identifi ed mouse and human NKG2D ligands up-regulated in nontumor cell lines by genotoxic stress and stalled DNA replication (43) . In their in vitro model, expression of the novel NK receptor ligands was dependent on the ataxia telangiectasia, mutated pathway. Thus, they propose "a novel link between the immune response and processes that regulate genome integrity" (43) . Alternatively, in our system, NMHC-II could be released into circulation or the extracellular space and bound by antibody. Attempts to measure specifi c release of NMHC were unsuccessful to date. As more specifi c reagents are developed, it will be important to identify the kinetics of exposure/release by hypoxic cells. Thus, in the absence of IgM as in RAG-1 −/− mice or peptide blocking of IgM with N2 or P8, we speculate that cell injury is reversible at least within the conditions of ischemia used in the current experiments. Of course, prolonged hypoxia would lead to irreversible cell injury and cell death independent of the innate immune system.
Although our experiments suggest that NMHC-II is the major antigen exposed during reversible RI, other epitopes are likely exposed on the surface of injured endothelium but in the absence of specifi c natural IgM are insuffi cient to mediate infl ammation. Support for additional antigens comes from recent reports by Fleming et al. (44, 45) . Using a similar model of mesenteric RI, they reported that murine and human antibodies specifi c for phospholipids (PLs) and/or β-2 glycoprotein could restore injury in Cr2 −/− or RAG-1 −/− animals. Because the murine anti-PL and β-2 antibodies are of the IgG subclass and were isolated from autoimmune mice (NZW × BxSB F1), they likely represent high-affi nity antibodies that arose as a result of autoimmune disease. Similarly, IgG antibodies from 5-mo-old but not 2-mo-old B6.MRL/ lpr autoimmune-prone mice are pathogenic in RI-treated RAG-1 −/− mice. Whether natural IgM of similar specifi city occur in nonautoimmune animals is unclear. However, given that pretreatment of WT mice with N2 or P8 peptides blocks injury in our two models, antibodies specifi c for self-antigens, such as PL or β-2 glycoprotein I, are not likely involved in the initiating event. However, after induction of RI it is clear that many additional self-antigens are released and become targets for self-specifi c natural IgMs. This could explain the observation by Fleming et al. (45) that mesenteric ischemic in the B6.MRL/lpr strain is more severe than WT controls as they express a higher level of self-reactive antibodies of both IgM and IgG subclasses (46) .
The pharmokinetics of N2 peptide are yet to be completely elucidated, but an initial serum concentration of ‫-23ف‬ 40 μM is suffi cient to block substantial injury in ischemic RAG-1 −/− mice administered IgM or WT mice over the 3 h of reperfusion. Because the peptide likely has a very short half-life in serum, it either binds with suffi cient high affi nity to the IgM to inhibit recognition of ligand over the complete period of reperfusion, or the ligand is only exposed transiently on reperfusion and peptide is only required after initial reperfusion. The kinetics of peptide binding determined by Biacore assay suggest that the former is unlikely and, therefore, we favor the latter possibility. Earlier studies in a rat myocardial RI model identifi ed increased myocardial injury 7 d after ischemia (10) . Injury was complement dependent, as pretreatment with a soluble inhibitor of C3 considerably reduced late injury. A limitation of the intestinal model is that injured microvilli are replaced by newly migrating enterocytes that emanate from stem cells in the crypts (47) . Although it seems likely that pretreatment with peptide will block late injury as it does acute, these studies will be important to follow up in the skeletal or cardiac muscle models.
Given the highly conserved nature of the N2 region, it is possible that exposure of other forms of myosin Hc, such as smooth muscle, could also serve as a target for natural antibody. However, it is notable that only NMHC-II A and C isoforms were identifi ed in the immune precipitation analyses, suggesting that these are the major antigens exposed/expressed during ischemia, at least in the intestine. It will be important to characterize the IgM-self-antigen complexes in the hindlimb model. Natural IgM, which is a product of innate lymphocytes (i.e., B-1 cells), is considered a component of innate immunity because of its germ line-encoded repertoire, absence of somatic mutation, and specifi city for structures highly conserved among both prokaryotes and eukaryotes (35) (36) (37) (38) . Therefore, it is not surprising that a highly conserved region of myosin could also serve as a target for natural IgM.
It is proposed that natural antibody recognition of the N2 epitope is conserved among vertebrates, as identifi ed for other B-1 cells such as for T-15 specifi city. Natural IgM of the T-15 specifi city binds oxidized lipids and phosphoryl choline (38) . Moreover, like anti-phosphoryl choline natural IgM, the serum levels of N2-specifi c antibody probably also vary among mice. If so, it will be important to test whether N2-specifi c antibody levels correlate with susceptibility to RI. Furthermore, we propose that this innate response to a stress-induced self-antigen represents a general mechanism referred to as "innate autoimmunity" (29, 30) . This novel concept was recently proposed to explain a role for Toll-like receptors in mediating sterile infl ammation in response to self-ligands (29) . Our observation that a natural antibody recognizes a highly conserved self-antigen, resulting in sterile infl ammation and tissue destruction, extends this notion to other pathways of innate recognition. Although a response to NMHC-II by Toll-like receptors was not examined, it is possible that they could participate in a secondary role as cells dying as a result of infl ammation release other potential selfligands. Similarly, other components of innate recognition such as mannan-binding lectin (MBL) (48) , surfactants (49, 50) , and C1q (51), which are known to bind and clear apoptotic cells, could play a secondary role after cell injury. Recently, Hart et al. reported the novel observation that injury in a mesenteric model of RI is dependent on MBL and complement C2 but not C1q (34) . Based on the importance of IgM and C4, it was assumed that injury was mediated via the classical pathway. We propose that IgM initiates the lectin pathway based on preliminary experiments indicating IgM deposition but an absence of C4 or C3 binding in MBL-a/c double-defi cient mice (unpublished data). Thus, recognition of NMHC-II and deposition of IgM either facilitates binding of MBL to IgM or exposes an MBL binding site on ischemic tissue leading to its activation.
RI represents a major health problem because it aff ects most tissues, including the intestine, myocardium, and central nervous system, and at present there are no eff ective therapies or treatment (52) . Intestinal ischemia, particularly the acute form, has a high mortality rate (70-90%) (53) . The identifi cation of a common epitope that is conserved among vertebrates and represents the target for natural IgM in a murine model of RI could provide a basis for development of a new category of therapeutics. Indeed, our fi nding that N2 peptide inhibits RI in two distinct tissues supports the feasibility of the approach.
In summary, we have identifi ed a conserved region of myosin Hc that serves as the target for natural IgM in two murine models of RI. It is proposed that this pathway represents a novel response by the innate immune system to selfantigens induced by hypoxia or other forms of cell stress.
MATERIALS AND METHODS
Phage display peptide library and peptide synthesis. A 12-mer M13 phage display library (New England BioLabs, Inc.) was screened for four rounds with MBL beads coated with IgM CM-22 and counterselected by one round of rat IgM followed by one round of IgM CM-75 , according to the manufacturer's recommendation. Phage clones were selected from the enriched pool, and the nucleotide sequence of the relevant phage gene was determined for <10 clones. Selected peptides were synthesized with a purity >95% in the Harvard Proteomic Core or New England Peptide, Inc.
Binding assays. ELISA was performed as described previously (27) . In brief, IgM binding to phage or phage-specifi c peptides was determined by coating a 96-well plate with saturating amounts of antigen. Subsequent to blocking, 1 or 10 μg/ml IgM was added for 2 h at 37°C. Plates were washed and developed with alkaline phosphatase-labeled goat anti-mouse IgM (Sigma-Aldrich). To detect binding of IgM to NMHC-II, plates were coated with specifi c rabbit IgG, and fresh intestinal lysate was added as a source of antigen. Subsequently, plates were washed, a source of natural IgM (i.e., IgM or IgM CM-31 ) was added, and binding was detected as described in the previous sentence. The following rabbit antibodies were used: NMHC-II A and B (Covance Inc.), NMHC-II C (a gift from R. Adelstein, National Institutes of Health [NIH], Bethesda, MD), and panmyosin Hc (Sigma-Aldrich). Lysates were prepared as described in Immune precipitation.
Intestinal RI model. RAG-1 −/− and C57BL/6 mice used in this study were purchased from Jackson ImmunoResearch Laboratories and maintained within the mouse colony under specifi c pathogen-free conditions at Harvard Medical School according to NIH guidelines on animal welfare. Procedures involving animals were approved by the Institutional Review Boards at the CBR Institute, Harvard Medical School, Massachusetts General Hospital, and Brigham and Women's Hospital. Surgical protocol for RI was performed as previously described (27) . In brief, a laparotomy is performed, a microclip (125 g pressure; Roboz) is applied to the superior mesenteric artery, and bilateral circulation is limited with silk sutures fl anking a 20-cm segment of the jejuneum. After 40 min of ischemia, the microclip was removed, and reperfusion of the mesenteric vasculature was confi rmed by the return of pulsation to the vascular arcade and a change to pink color. The incision was closed, and all animals were kept warm for 3 h. Reconstituted RAG-1 −/− animals received either IgM mixed with peptide or saline in 0.2 ml volume i.v. 30 min before the initial laparotomy. WT animals were treated with saline or peptide i.v. 5 min before reperfusion. At the end of reperfusion, the ischemic segment of the jejunum was harvested, and the central 4 cm was cut for pathological analysis.
Hindlimb RI model. 8-12-wk-old WT mice underwent 2 h of hindlimb ischemia and 3 h of reperfusion as previously described (28) . In brief, bilateral rubber bands (Latex O-Rings; Miltex Instruments) were applied above the greater trochanter. Rubber bands were removed, and limb reperfusion was confi rmed by return of pink color. Tissues were fi xed for 8 h in 4% paraformaldehyde and sectioned for Masson's Trichrome staining. 50 individual muscle fi bers were counted per section, and the injury was reported as the number of damaged fi bers per 50 fi bers counted.
Histopathology and immunohistochemistry analysis. Cryostat sections of intestinal tissues were stained by hematoxylin and eosin and examined by light microscopy for mucosal damage. Pathology score was assessed based on a procedure modifi ed from Chiu et al. (54) that included direct inspection of all microvilli over a 4-cm stretch of jejuneum, as described previously (27) . In brief, the integrated injury score
, where V = total number of villi; S = villi appearing with subepithelial space, defi ned as an acellular space under a continuous epithelial layer and a milder form of damage; D = villi appearing with epithelial disruption, defi ned as discontinuation of an epithelial layer of villus and a more severe form of damage; and P = villi lost over the length of intestine measured using a 100× fi eld (each fi eld has an average of 25 jejunal villi; thus, by aligning the intestinal wall through the center of each power fi eld, an estimate of the number lost can be made). For immunofl uorescence, cryosections fi xed with 4% (wt/vol) paraformaldehyde were incubated for varying periods with biotin-labeled anti-mouse IgM (Becton Dickinson), followed by 1 h with streptavidinAlexa 568 (Invitrogen). C4 deposition was detected by staining with FITClabeled rabbit anti-huC4c (DakoCytomation), followed by anti-rabbit-Alexa 488 (Invitrogen). The specifi city of anti-C4c staining was confi rmed by staining serial sections with biotin-labeled anti-mouse C4 for 1 h followed by streptavidin-FITC (Becton Dickinson). C3 deposition was detected by treating with FITC-labeled anti-C3 (DakoCytomation). Sections were mounted in antifade mounting medium with DAPI (Invitrogen).
SPR analysis of peptide binding to antibody. IgM (IgM CM-22 or CM-31 ) antibody was immobilized by amine coupling in a chip (SPR CM5; Biacore) fl owcell at a density of 33,400 response units per ‫33ف‬ ng/mm 2 as described previously (55) . A reference fl ow cell was prepared by coupling of ethanolamine-HCl. Peptides, diluted in PBS running buff er, were fl owed separately over the IgM-coupled surface and the reference at a rate of 10 μl/min at 25°C, with the data collection rate at 10 Hz. The injection phase had a duration of 240 s (the ends of injection phases are marked by arrow heads). Binding isotherms were derived by subtracting the response in the reference cell from the response of the IgM-coupled surface. After each run, the surface was regenerated by injecting 40 μl 0.05% (vol/vol) polyoxyethylenesorbitan monolaureate/PBS.
Immune precipitation. Frozen tissues were homogenized in a lysis buff er containing detergent and a cocktail of enzyme inhibitors. A sample of lysate is analyzed for total protein content (protein assay dye; Bio-Rad Laboratories) to ensure similar levels of protein for analysis. Lysates are mixed with sepharose beads coated with rat anti-mouse IgM for 1 h at 4°C. Subsequently, beads were pelleted gently, washed in lysis buff er, and boiled in SDS sample buff er under reducing conditions to elute bound complexes. Samples were fractionated on 8% (wt/vol) polyacrylamide SDS gels and subsequently fi xed and stained with either Coomassie blue or silver stain to identify protein bands.
Protein identifi cation by tandem mass spectrometry. Individual Coomassie-stained bands were excised from SDS gels, destained, and subjected to enzyme digestion as described previously (56) . The peptides were separated using a nanofl ow liquid-coupled chromatography system (CapLC; Waters), and amino acid sequences were determined by tandem mass spectrometer (Q-Tof micro; Waters). Mass spectrum (MS)/MS data were processed and subjected to database searches using Mascot (Matrix Science) against the UniProtKB/Swiss-Prot, TrEMBL-NEW, or the NCBI nonredundant databases.
Intestinal permeability. Intestinal permeability was determined by measuring the appearance of HRP in blood (molecular mass = 40 kD; SigmaAldrich) administered by gavage as described previously (57) . The model used for investigating intestinal permeability was basically identical to the surgical protocol described in Intestinal RI model, except bilateral circulation limitation with silk sutures was not performed to maintain an open lumen during the study. In brief, 10 min before intestinal RI was induced, mice were administered 10 µl/g body weight of phosphate-buff ered saline ARTICLE (pH 7.4) containing 2 mg/ml HRP by gavage. To test the blocking eff ect of N2 peptide in intestinal RI, WT C57BL/6 mice were treated with saline or peptide (fi nal serum concentration = 40 µM) in a volume of 100 µl i.v. 5 min before reperfusion. Blood samples were obtained in a capillary tube 3 h after reperfusion by retroorbital puncture. Blood samples were allowed to clot overnight at 4°C and centrifuged (3,000 rpm) for 10 min. Serum samples were diluted and added to a 96-well microplate (Nalge Nunc) precoated with goat anti-HRP antibody (1:2,500 dilution; Sigma-Aldrich). The plate was then incubated for 2 h at 37°C, after which the wells were washed three times with phosphate-buff ered saline (pH 7.4) and 0.1% Tween 20. HRP activity was determined by adding 100 µl of reagent (TMB One-Step Substrate System; DakoCytomation) for 15 min, and the reaction was stopped with 100 µl 2N H 2 SO 4 . The concentration of HRP was determined by spectrometry at 450 nm.
Vascular leakage. Leakage was determined in real time using an intravital imaging approach combined with a novel scanning laser confocal microscope (prototype scanner from Olympus Corp.) and a vascular probe (AngioSense 680; VisEn Medical) as described previously (58) . Mice were anesthetized with a 0.3-ml i.p. injection of 15 mg/ml ketamine Hcl and 3 mg/ml xylazine and injected i.v. with AngioSense 680 (10 nmol/mouse) and Rhodamine 6G (Invitrogen) 5 min before reperfusion. Mice treated for intestinal RI (see Intestinal permeability) and sham controls were prepared for imaging before reperfusion by making a small incision within the wall of the exposed jejuneum and inserting the "stick-lens" (1.3 mm diameter) of the prototype confocal setup. Imaging of the microvilli was initiated 15 min after reperfusion and continued for up to 45 min. Images were prepared at varying time points after reperfusion. Results from representative images of the three groups of mice (i.e., sham, saline, and N2 peptide) were analyzed by imaging software (Image J version 1.34; Wayne Rasband, NIH, Bethesda, MD) by taking 10 measurements of representative fi elds of view, and the intensity of red dye within the target vessels (V) versus surrounding background (B) tissue was determined. Results were calculated as ratio of V/B intensity ± SD.
Statistical analysis. Data in all fi gures (except Fig. 6 , in which SD is used) are expressed as means ± SEM. Statistical comparisons between groups were made by Student's t test, and ANOVA was used for comparisons of multiple groups. P < 0.05 was considered signifi cant.
